144 related articles for article (PubMed ID: 15601854)
1. Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway.
Wang X; Merritt AJ; Seyfried J; Guo C; Papadakis ES; Finegan KG; Kayahara M; Dixon J; Boot-Handford RP; Cartwright EJ; Mayer U; Tournier C
Mol Cell Biol; 2005 Jan; 25(1):336-45. PubMed ID: 15601854
[TBL] [Abstract][Full Text] [Related]
2. The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer.
Cristea S; Coles GL; Hornburg D; Gershkovitz M; Arand J; Cao S; Sen T; Williamson SC; Kim JW; Drainas AP; He A; Cam LL; Byers LA; Snyder MP; Contrepois K; Sage J
Cancer Res; 2020 Mar; 80(6):1293-1303. PubMed ID: 31969375
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic signaling of MEK5-ERK5.
Hoang VT; Yan TJ; Cavanaugh JE; Flaherty PT; Beckman BS; Burow ME
Cancer Lett; 2017 Apr; 392():51-59. PubMed ID: 28153789
[TBL] [Abstract][Full Text] [Related]
4. Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications.
Sánchez-Fdez A; Matilla-Almazán S; Del Carmen S; Abad M; Arconada-Luque E; Jiménez-Suárez J; Chinchilla-Tábora LM; Ruíz-Hidalgo MJ; Sánchez-Prieto R; Pandiella A; Esparís-Ogando A
Exp Mol Med; 2023 Jun; 55(6):1247-1257. PubMed ID: 37332046
[TBL] [Abstract][Full Text] [Related]
5. The high-mobility-group box protein SSRP1/T160 is essential for cell viability in day 3.5 mouse embryos.
Cao S; Bendall H; Hicks GG; Nashabi A; Sakano H; Shinkai Y; Gariglio M; Oltz EM; Ruley HE
Mol Cell Biol; 2003 Aug; 23(15):5301-7. PubMed ID: 12861016
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer.
Matossian MD; Hoang VT; Burks HE; La J; Elliott S; Brock C; Rusch DB; Buechlein A; Nephew KP; Bhatt A; Cavanaugh JE; Flaherty PT; Collins-Burow BM; Burow ME
Oncoscience; 2021; 8():64-71. PubMed ID: 34026925
[TBL] [Abstract][Full Text] [Related]
7. Involvement of MEK5/ERK5 signaling pathway in manganese-induced cell injury in dopaminergic MN9D cells.
Ding H; Wang F; Su L; Zhao L; Hu B; Zheng W; Yao S; Li Y
J Trace Elem Med Biol; 2020 May; 61():126546. PubMed ID: 32480051
[TBL] [Abstract][Full Text] [Related]
8. A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancer.
Odongo R; Demiroglu-Zergeroglu A; Çakır T
BioData Min; 2024 Feb; 17(1):5. PubMed ID: 38378612
[TBL] [Abstract][Full Text] [Related]
9. The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma.
Rovida E; Di Maira G; Tusa I; Cannito S; Paternostro C; Navari N; Vivoli E; Deng X; Gray NS; Esparís-Ogando A; David E; Pandiella A; Dello Sbarba P; Parola M; Marra F
Gut; 2015 Sep; 64(9):1454-65. PubMed ID: 25183205
[TBL] [Abstract][Full Text] [Related]
10. Bone and Extracellular Signal-Related Kinase 5 (ERK5).
Wen L; Liu Z; Zhou L; Liu Z; Li Q; Geng B; Xia Y
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785963
[TBL] [Abstract][Full Text] [Related]
11. MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists.
Espinosa-Gil S; Ivanova S; Alari-Pahissa E; Denizli M; Villafranca-Magdalena B; Viñas-Casas M; Bolinaga-Ayala I; Gámez-García A; Faundez-Vidiella C; Colas E; Lopez-Botet M; Zorzano A; Lizcano JM
Cell Death Dis; 2023 Nov; 14(11):715. PubMed ID: 37919293
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Signal-Regulated Kinases Play Essential but Contrasting Roles in Osteoclast Differentiation.
Kim C
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895023
[TBL] [Abstract][Full Text] [Related]
13. TRAF7 is an essential regulator of blood vessel integrity during mouse embryonic and neonatal development.
Tsitsikov EN; Phan KP; Liu Y; Tsytsykova AV; Kinter M; Selland L; Garman L; Griffin C; Dunn IF
iScience; 2023 Aug; 26(8):107474. PubMed ID: 37583551
[TBL] [Abstract][Full Text] [Related]
14. VEGF Stimulates Activation of ERK5 in the Absence of C-Terminal Phosphorylation Preventing Nuclear Localization and Facilitating AKT Activation in Endothelial Cells.
Mondru AK; Aljasir MA; Alrumayh A; Nithianandarajah GN; Ahmed K; Muller J; Goldring CEP; Wilm B; Cross MJ
Cells; 2023 Mar; 12(6):. PubMed ID: 36980305
[TBL] [Abstract][Full Text] [Related]
15. Putative Animal Models of Restless Legs Syndrome: A Systematic Review and Evaluation of Their Face and Construct Validity.
Silvani A; Ghorayeb I; Manconi M; Li Y; Clemens S
Neurotherapeutics; 2023 Jan; 20(1):154-178. PubMed ID: 36536233
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting ERK5 overcomes breast cancer resistance to anti-HER2 therapy by targeting the G1/S cell cycle transition.
Zhang J; Pearson AJ; Sabherwal N; Telfer BA; Ali N; Kan K; Xu Q; Zhang W; Chen F; Li S; Wang J; Gray NS; Risa-Ebrí B; Finegan KG; Cross MJ; Giurisato E; Whitmarsh AJ; Tournier C
Cancer Res Commun; 2022 Mar; 2(3):131-145. PubMed ID: 36466034
[TBL] [Abstract][Full Text] [Related]
17. ERK5 Signalling and Resistance to ERK1/2 Pathway Therapeutics: The Path Less Travelled?
Cook SJ; Lochhead PA
Front Cell Dev Biol; 2022; 10():839997. PubMed ID: 35903549
[TBL] [Abstract][Full Text] [Related]
18. The Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase Pathway in Osteoblasts.
Greenblatt MB; Shim JH; Bok S; Kim JM
J Bone Metab; 2022 Feb; 29(1):1-15. PubMed ID: 35325978
[TBL] [Abstract][Full Text] [Related]
19. The MEK5/ERK5 Pathway in Health and Disease.
Paudel R; Fusi L; Schmidt M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299213
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
